v3 Template
R

Remepy

Healthcare / Pharmaceuticals ~380 employees
Founded
--
Employees (Est.)
~380
19 leaders known
Total Funding
$15.0M
Funding Rounds
1
Last Funding
2024-05-01

About Remepy

Remepy is pioneering hybrid drugs, redefining combination therapy by integrating unique adaptive multi-modality protocols to enhance drug effectiveness. Their vision is to standardize, make accessible, and personalize combination therapies at scale using innovative AI-driven digital treatment protocols.

Products & Services

Hybrid Drugs:A novel line of hybrid drugs combining software with pharmaceuticals to create a new SaMD-Drug combination, offering personalized data and treatment opportunities. Includes a therapeutic app with tailored motor, cognitive, psychological, and behavioral interventions.
Parkinson's Disease Treatment:Hybrid drug treatment for Parkinson's Disease, validated in a successful double-blind placebo-controlled randomized study, with a phase 3 pivotal study planned for H2/2025.
Oncology Solutions:Hybrid drug interventions targeting oncology, specifics not detailed in content.

Specialties

Hybrid Drugs Digital Interventions AI-Driven Digital Treatment Protocols Non-Invasive Cognitive and Motor Interventions Neuroplasticity Immune System Modulation Parkinson's Disease Treatment

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Seed
T: -
FT: Seed 		A: 15000000
MR: -
FA: $15M
FAN: 15000000 		D: 2024-05-01
FD: 2024-05-01 		10 investors
Seed Latest
2024-05-01
$15.0M
10 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

O

Or Shoval

Co-CEO

LinkedIn (Pro only)
M

Michal Tsur

Co-CEO

LinkedIn (Pro only)
A

Amir Amedi

Chief Scientific Officer

LinkedIn (Pro only)
E

Eran Etam

CTO

R

Ran Buck

President and CBO

N

Nira Saporta

Chief Therapeutics Officer

View 16 more team members with Pro

Unlock Full Team Directory

Recent News

Remepy Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
remepy.com
Industries
Healthcare / Pharmaceuticals
Company Size
~380 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro